Tessera Therapeutics Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- Tessera Therapeutics's estimated annual revenue is currently $45.4M per year.
- Tessera Therapeutics's estimated revenue per employee is $142,367
- Tessera Therapeutics's total funding is $431.8M.
- Tessera Therapeutics's current valuation is $1.7B. (April 2022)
- Tessera Therapeutics has 319 Employees.
- Tessera Therapeutics grew their employee count by 50% last year.
Tessera Therapeutics Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Tessera Therapeutics?
Our mission is to cure disease by writing the code of lifekeywords:N/A
Number of Employees
Employee Growth %
Tessera Therapeutics News
2022-04-17 - Tessera Therapeutics Raises Over $300M in Series C Financing
Tessera Therapeutics, a Somerville, MA-based biotechnology company, raised over $300M in Series C funding.
2022-04-17 - Tessera Therapeutics stacks up more than $300M in series C funds ...
Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million...
2022-04-17 - Tessera Therapeutics Announces Over $300M Series C Financing ...
Tessera Therapeutics is pioneering GENE WRITING technology, which consists of multiple technology platforms designed to offer scientists and...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|